Navigation Links
The University of Maryland Baltimore (UMB) and Paragon Bioservices, Inc. Announce the Formation of a Public-Private Stem Cell Technology Consortium
Date:4/28/2011

BALTIMORE, April 28, 2011 /PRNewswire/ -- UMB's Center for Stem Cell Biology and Regenerative Medicine and Paragon Bioservices, Inc., a contract research and GMP manufacturing organization with its headquarters at the University of Maryland BioPark, announced today the formation of a public-private partnership for developing and manufacturing stem cell therapies.

Dr. Curt I. Civin, Director of the University of Maryland's Center for Stem Cell Biology and Regenerative Medicine, a pioneer in cancer research and an internationally renowned physician-scientist who has made significant contributions in the field of blood-forming stem cell transplantation, stated "The main objective of the consortium is to accelerate the development of novel strategies for regenerative medicine, including new treatments and preventatives derived from stem cell research."

The Center will collaborate with Paragon Bioservices to establish a core facility that will offer stem cell services on a fee-for-service basis.  The services offered include cell banking and production of a variety of stem cell types.  Stem cells will be available for research purposes and, eventually, for clinical use. http://www.paragonbioservices.com/Research-Services/Stem-Cell-Services.aspx

The Consortium is being funded in part by a "Translational Research Award " from the Maryland Biotechnology Center.  According to Dr. Judy Britz, The MBC's Executive Director, "The Maryland Biotechnology Center evaluated 60 proposals and The Consortium effectively competed for its award since it is dedicated to crossing the translational medicine divide, creates a model for sustainability and increases the likelihood of commercialization of new technologies."

Dr. Marco Chacon, Paragon's President & CEO, commented, "It is an honor to work with Dr. Civin as well as a privilege to play a role in the development of interesting technologies that could have a positive impact on public health and the economic development of our community."

The partnership also includes Life Technologies, Inc., a global biotechnology company that is a provider of scientific products and reagents.  LTI already provides innovative solutions for scientists engaging in stem cell research.  So—as part of their corporate commitment to global social responsibility—they will be providing training opportunities for research scientists.

As a partnership for better public health, the Consortium is openly seeking wider participation from other research institutions, State and Federal agencies, and private companies.Contact:

Dr Aaron HeifetzBusiness DevelopmentStem Cell Technologies & Regenerative MedicineAbout Paragon Bioservices, Inc.Paragon Bioservices is a contract research and manufacturing organization (CMO) that provides a comprehensive portfolio of services—from research services and process development to cGMP manufacturing of monoclonal antibodies, therapeutic proteins, vaccines (VLPs), and stem cells.  The corporate focus is to bridge the translational divide and enable protein and cell-based therapeutics to move into clinical trials.  www.paragonbioservices.com

Media Contact for Paragon Bioservices:
Tiberend Strategic Advisors, Inc.
212-827-0020
Tamara Bright
tbright@tiberend.com
or
Claire Sojda
csojda@tiberend.com


'/>"/>
SOURCE Paragon Bioservices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011
2. Tomophase Announces First Sale of Its OCT Imaging System (OCTIS™) for Research Use to the University of Texas
3. Nanocrystal doping developed by Hebrew University researchers enhances semiconductor nanocrystals
4. Selexis SA and the University of Lausanne Announce the Complete Sequencing of the Selexis SURE CHO-M Genome
5. China PharmaHub In-Licenses Universal Donor Red Blood Cells Technology Exclusively From University of California, San Diego
6. Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition
7. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
8. Queens University professor uses nanotechnology to prolong machine and engine life
9. Binghamton University nanoscientist chosen for the Air Forces Young Investigator Research Program
10. Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
11. Georgia Health Sciences University Clinical Study Shows RyMed InVision-Plus® IV Connector Significantly Decreased Central Venous Catheter Occlusions in Oncology Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... July 20, 2017   KCNQ2 Cure Alliance ... evaluations company, today announced that they have completed ... genetic mutation implicated in KCNQ2 epileptic encephalopathy. They ... a second case involving an additional KCNQ2 genetic ... Alliance and Pairnomix entered into a collaboration to ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to make clinical trial sites and study participants truly unified. TrialKit, a native ... (FDA 21 CFR Part 11) research studies entirely on mobile devices. With TrialKit, ...
(Date:7/18/2017)... ... July 18, 2017 , ... Sourcing custom glass or quartz parts can be ... capabilities to properly execute your job can take many hours of emails, phone calls ... portal designed to showcase the company’s capabilities and core custom categories, and enables you ...
(Date:7/18/2017)... ... , ... G-CON today announced that it has received Notices ... Applications 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile Clean Room. The U.S. ... of G-CON’s R&D investments and validate the G-CON platform as a novel way ...
Breaking Biology Technology:
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
(Date:3/23/2017)... Mar. 23, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 8.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
Breaking Biology News(10 mins):